Release Date: 01/11/16 08:09 Summary: Quarterly Activities Report & Appendix 5B - September 2016-BSP.AX Price Sensitive: Yes Download Document 326.02KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status